Oncology Oncology Manufacturers' Perception - Insights from the Healthcare Frontline Leaders of Oncologist’s Perceptions: Who are they and what sets them apart In the highly competitive oncology therapeutics landscape, there is a direct correlation between oncologists’ preferences and financial success. That makes
Oncology Mindshare Masters: Top Oncology Brands that Oncologists Trust Have you ever wondered which oncology brands truly dominate and capture the mindshare oncologists in the ever-evolving field of oncology? With a staggering 100+ new molecular entities approved by the FDA (Feder
Launch Excellence From Triumph to Competition: Humira's Journey and the Rise of Biosimilars Humira, a name synonymous with swiss knife. It is a drug that could treat all conditions from Rheumatoid arthritis to Ulcerative Colitis. It is a blockbuster drug that rose to prominence amidst challenges
Launch Excellence Advancing Schizophrenia Treatment: Exploring UZEDY and Abilify Asimtufii Introduction: Schizophrenia, a complex mental health condition, requires ongoing management to enhance the quality of life for individuals affected by it. Recent advancements in medical science have introduced two innovative treatments: UZEDY and
Launch Excellence A Game-Changer for Narcolepsy: Lumryz (Sodium Oxybate) Takes Center Stage with Once-Nightly Dosing Introduction: Living with narcolepsy can be challenging, especially when excessive daytime sleepiness and cataplexy disrupt daily life. Lumryz (sodium oxybate), a once-nightly extended-release oral suspension, offers new hope for patients. In this blog
What HCPs Really Think: A Revealing Look at Industry Leaders & Challengers in 5 Therapeutic Areas Healthcare providers (HCPs) are crucial decision-makers in prescribing and recommending treatments to patients. As such, their perceptions and opinions of pharmaceutical manufacturers and their products are highly relevant. Recent research indicates that two-thirds
Launch Excellence Arexvy: A Promising Breakthrough in RSV Prevention for Older Adults Introduction: ZoomRx is excited to share the latest developments regarding Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults. Recently approved by the US Food and Drug Administration (FDA), Arexvy
Launch Excellence Transforming Post-HCT Care for Blood Cancer Patients - Insights from Oncologists Introduction: Omisirge, the revolutionary stem cell therapy developed by Gamida Cell, has recently received FDA approval and is poised to revolutionize the post-HCT (hematopoietic stem cell transplantation) journey for patients with blood cancers.
Launch Excellence Zavzpret: An Intranasal Gepant for Migraine Relief - Neurologists Weigh In Zavzpret, a new nasal spray from Pfizer, was approved by the FDA in March 2023 for the acute treatment of migraines. The drug is a calcitonin gene-related peptide (CGRP) receptor antagonist and works
Launch Excellence Zynyz for Merkel Cell Carcinoma: A Highly Effective but Little Known Treatment Option? Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that can be challenging to treat. Until recently, treatment options were limited, but with the advent of immunotherapy, new therapies
Launch Excellence Airsupra: The Rescue Inhaler That Helps Manage Asthma Symptoms Asthma is a chronic respiratory disease that affects millions of people worldwide. It causes inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, coughing, and chest tightness.
Launch Excellence Rykindo: A New Long-Acting Injectable Formulation of Risperidone for Schizophrenia and Bipolar I Disorder The pharmaceutical industry is constantly evolving, and one of the latest additions to the market is Rykindo, a long-acting injectable formulation of risperidone. Risperidone is an atypical antipsychotic medication used for the treatment
Launch Excellence Jaypirca: A Fresh Approach to Later-Line MCL Treatment Jaypirca (pirtobrutinib) is a novel, non-covalent Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic
Launch Excellence Leqembi's First 2 Months on the Market: Neurologists Feedback Leqembi (lecanemab) is a new Alzheimer's disease treatment option from Biogen/Eisai. The drug has a unique mechanism of action that is thought to slow down the progression of the disease by neutralizing
Launch Excellence The Latest Addition to Diabetes Treatment: A Deep Dive into Brenzavvy Type 2 diabetes is a chronic disease that affects millions of people worldwide. It is characterized by high levels of sugar in the blood due to the body's cells resisting the normal effect
Launch Excellence Hope for Patients with Anemia of CKD: FDA Approves Jesduvroq GSK plc has announced the FDA approval of Jesduvroq (daprodustat) for the treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.
Customer Engagement Physicians' View of the Industry Giants: Ranking the Top Pharma Companies The pharmaceutical industry is constantly evolving, and the perceptions of healthcare professionals (HCPs) play a critical role in shaping the public's trust and acceptance of drugs. To understand how physicians perceive the top
Launch Excellence The Launch of Amjevita: The First Humira Biosimilar The world of autoimmune treatments has seen a new addition with the launch of Amjevita, the first Humira biosimilar. Humira, the swiss knife medication, has been available in the US since 2002 and
Digital Big Tech's Impact on Healthcare and Physician Perspectives "If you zoom out into the future and you look back and ask the question, 'What was Apple's greatest contribution to mankind?' It will be about health." - Tim Cook, Apple CEO
Oncology Oncology Commercial Leadership: Traits of Top Oncology Sales Reps Success strategies of the leading oncology sales reps Many factors contribute to the success of any oncology therapy, beginning with efficacy. Yet, widespread uptake relies on physician prescribing power—and oncologists’ willingness to
Digital Tracker Top 10 Pharma Websites Where Oncologists Spend Time The digital landscape is incredibly diverse and saturated. In order to effectively reach your target customers and have a meaningful impact, you need to understand your customer preferences. Our omnichannel intelligence tool, Digital
Oncology Oncologists share exclusive insights on the developments in breast cancer therapies in the past year Breast Cancer Awareness Month (BCAM) is a time to celebrate the strength of breast cancer survivors and to champion all of those who are fighting to eradicate this group of diseases. At ZoomRx,
Digital Tracker Going Beyond Impressions: Learnings from Digitally Active Oncology Brands Here, we combine PERxCEPT's digital tracking technology with our agile market research techniques to reveal the true impact of the most widespread digital campaigns on HCP perceptions and real-world behavior.
Oncology Cancer Moonshot: Oncologists express optimism about cutting cancer-related deaths Oncologists on the ZoomRx panel express their thoughts on the Cancer Moonshot initiative.
Customer Engagement Returning to In-Person Promotion: Physician Expectations for Sales Rep Vaccination As the COVID-19 vaccine rollout continues in the United States, sales teams across the pharmaceutical industry are considering how and when to increase the volume of in-person promotion.
